Dr Adeola Ayoola

Influenza Vaccine effectiveness during cancer treatment. This study answers an important clinical question, how effective is influenza vaccine on patients who are on treatment for various types of cancer. As we know, Influenza virus infection has significant morbidity and mortality in those with medical conditions and who are immunosuppressed. We assessed the efficacy of seasonal influenza vaccine in patients with non-haematological malignancy on active treatment (chemotherapy and targeted therapy). Efficacy of influenza vaccine (Fluvax) in cancer patients on treatment: a prospective single arm, open-label study. Supportive Care in Cancer, 2020.  

Stage III Lung cancer, chemoradiation, long term toxicity. The preferred management of patients with unresectable locally advanced non-small cell lung cancer (LA-NSCLC) is concurrent chemo-radiotherapy (CRT). This treatment has well documented short toxic side effects, however, less is known about late toxicities. We reviewed the long-term and any late toxicities in Stage III NSCLC treated with chemoradiotherapy. Survival and late toxicities following concurrent chemo-radiotherapy for locally advanced (stage iii) non-small cell lung cancer: findings of a 10-year Australian single centre experience with long term clinical follow up. Journal of Thoracic Disease, 2019. 11(10): 4241-4248.

A commentary on Liver directed therapy, Selective Internal Radiation Therapy (SIRT). In patients with metastatic colorectal cancer, liver metastatic-related complications remain one of the major causes of death. Selective internal radiation therapy (SIRT) is a liver-directed treatment that aims to achieve control of metastatic liver lesions that are not amenable to surgery. Previous studies have shown some activity as a salvage therapy in patients with chemo-refractory disease. SIRFLOX: Progression-free survival in the liver as a surrogate end point for survival. Journal of Clinical Oncology, 2016. 34(34): 4193.

Decision making in Testicular Cancer, Stage I. Involving patients in the treatment decision making process is an important aspect of patient-centred care. However, patient’s preferences for involvement are not always met. This was a retrospective survey study, which assessed a range of factors concerning the treatment decision making process of testicular cancer patients. Decision-making preferences and satisfaction of stage one testicular cancer patients. Asia-Pacific Journal of Clinical Oncology, 2016. 12(5): 23.

Decision aid, testicular cancer, Stage I. Chemotherapy or surveillance are recommended treatments for stage 1 testicular cancer patients, post-surgery. Both are effective but have distinct pros and cons that may be valued differently, thus making treatment decisions preference sensitive. Decision aids are effective and may help support these treatment decisions. Assessing the information needs of stage one testicular cancer patients and their Carers. Asia-Pacific Journal of Clinical Oncology, 2016. 12(5): 13.